Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2011
03/08/2011US7902239 Diaminotriazoles useful as inhibitors of protein kinases
03/08/2011US7902191 Histamine H3 receptor antagonists, preparation and therapeutic uses
03/08/2011US7902184 Piperazinyl pyrimidine derivatives
03/08/2011US7902181 Compounds 010
03/08/2011CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
03/08/2011CA2487532C Pyrrolidine derivatives as oxytocin antagonists
03/08/2011CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity
03/08/2011CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors
03/08/2011CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
03/03/2011WO2011025927A1 Compounds and compositions as protein kinase inhibitors
03/03/2011WO2011025546A1 1, 2, 3-triazole containing protein kinase sensors
03/03/2011WO2011025541A1 Cannabinoid receptor modulators
03/03/2011WO2011024078A1 3 -oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments
03/03/2011WO2011023989A1 Aromatase inhibitor
03/03/2011WO2011023773A1 Compounds and compositions as protein kinase inhibitors
03/03/2011WO2011023703A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
03/03/2011WO2011023680A2 Processes for the synthesis and purification of heterobifunctional cross-linkers
03/03/2011WO2011023677A1 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
03/03/2011WO2011023081A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
03/03/2011WO2010123919A3 Piperidine inhibitors of janus kinase 3
03/03/2011WO2008035209A3 Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity
03/03/2011US20110054181 Near infrared fluorescent imaging agent
03/03/2011US20110053980 Indane-amine derivatives, their preparation and use as medicaments
03/03/2011US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1
03/03/2011US20110053941 IDO Inhibitors
03/03/2011US20110053937 Inhibitors of the Interaction Between MDM2 and P53
03/03/2011US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
03/03/2011US20110053918 Gamma secretase modulators
03/03/2011US20110053916 Pyrimidine compounds as tuberculosis inhibitors
03/03/2011US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
03/03/2011US20110053891 5-fluoropyrimidinone derivatives
03/03/2011US20110053883 Agent that modulates physiological condition of pests, involved in insect c-jun amino-terminal kinase activity
03/03/2011US20110052674 Angiotensin ii receptor blocker derivatives
03/03/2011US20110049497 Material for organic electroluminescence device and organic electroluminescence device
03/03/2011US20110049495 Quinoxaline derivatives and organic light-emitting diodes comprising the same
03/03/2011US20110049487 Heteroarylamine compound and organic luminescence device using the same
03/03/2011US20110049484 Heteroarylamine compound and organic light-emitting device including the same
03/03/2011CA2772164A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
03/03/2011CA2771936A1 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
03/03/2011CA2771775A1 Compounds and compositions as protein kinase inhibitors
03/03/2011CA2771673A1 Compounds and compositions as protein kinase inhibitors
03/03/2011CA2770866A1 Cannabinoid receptor modulators
03/03/2011CA2770475A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
03/03/2011CA2769151A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
03/02/2011EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors
03/02/2011EP2289890A1 Compounds for the treatment of multi-drug resistant bacterial infections
03/02/2011EP2289882A1 3-oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments
03/02/2011EP2289881A1 Method for stereoselective synthesis of bicyclical heterocycles
03/02/2011EP2289877A1 Organic light emitting device containing polycyclic heteroaryl compounds
03/02/2011EP2288603A1 Tetrazole compounds as orexin receptor antagonists
03/02/2011EP2288602A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
03/02/2011EP2004601B1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
03/02/2011EP1966146B1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
03/02/2011EP1957481B1 Pyrrolidin(thi)ones heterocyclically substituted in 3-position
03/02/2011EP1957479B1 1,5-substituted indol-2-yl amide derivatives
03/02/2011EP1836176B1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEROF
03/02/2011EP1694654B1 Substituted triazoles as sodium channel blockers
03/02/2011EP1585737B1 Uracils having a herbicidal activity
03/02/2011EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
03/02/2011CN101983195A Novel polymorphs and processes for their preparation
03/02/2011CN101983188A Indolinone compound
03/02/2011CN101193869B Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/02/2011CN101104604B Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis
03/01/2011US7897780 Method for controlling phytopathogenic fungi using silylated carboxamides
03/01/2011US7897763 Process for the preparation of substituted phenylalanines
03/01/2011US7897634 Pyrazoles for the treatment of obesity and other CNS disorders
03/01/2011US7897633 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism
03/01/2011US7897631 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
03/01/2011US7897627 Heteroaryl derivatives as orexin receptor antagonists
03/01/2011US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists
03/01/2011US7897602 Indolinone compounds as kinase inhibitors
03/01/2011US7897599 Cytokine inhibitors
03/01/2011US7897596 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina
03/01/2011US7897593 HIV integrase inhibitors
03/01/2011US7897589 Substituted pyrazoline compounds, their preparation and use as medicaments
02/2011
02/24/2011WO2011022596A2 Preparation of bazedoxifene and its salts
02/24/2011WO2011022509A2 Substituted benzoazepines as toll-like receptor modulators
02/24/2011WO2011022508A2 Substituted benzoazepines as toll-like receptor modulators
02/24/2011WO2011022473A1 Biaryl compounds and methods of use thereof
02/24/2011WO2011022440A2 Heat shock protein binding compounds, compositions, and methods for making and using same
02/24/2011WO2011022348A1 Ethylene diamine modulators of fatty acid amide hydrolase
02/24/2011WO2011022312A1 Ether benzotriazole derivatives
02/24/2011WO2011021979A1 Cinnoline compounds, their preparation, and their use
02/24/2011WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition
02/24/2011WO2011021689A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
02/24/2011WO2011021216A2 Improved process for the preparation of 4-(1,1-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide
02/24/2011WO2011021209A1 Histone deacetylase inhibitors
02/24/2011WO2011020605A1 Process for the production of coevaporates and complexes comprising voriconazole and cyclodextrin
02/24/2011WO2011020567A1 3-triazolylphenyl-substituted sulfide derivatives for use as acaricides and insecticides
02/24/2011WO2011020288A1 Substituted hydrazide compounds and application thereof
02/24/2011WO2010121164A3 1,4-benzodiazepinone compounds and their use in treating cancer
02/24/2011WO2010118286A3 Benzimidazole modulators of h1 receptor and/or ns4b protein activity
02/24/2011WO2010104349A3 Compounds usable as materials for a hole injection layer or hole transport layer, and organic light-emitting diode using same
02/24/2011WO2010077663A3 Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof
02/24/2011US20110046599 Multi-Day Delivery Of Biologically Active Substances
02/24/2011US20110046397 New processes
02/24/2011US20110046390 Gas Generant Compositions
02/24/2011US20110046376 Methods for synthesizing heterocyclic compounds.
02/24/2011US20110046367 3-3-di-substituted-oxindoles as inhibitors of translation initiation
02/24/2011US20110046194 3-Triazolylphenyl-substituted sulphide derivatives as acaricides and insecticides